Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder
The purpose of this study is to determine and compare the effect of this treatment on recurrence rate and to assess the toxicity in both arms of patients with STCC. Other objectives include determining the effects of this treatment on quality of life, and comparing the effect of Mycobacterium w on time to tumor progression.
Bladder Cancer
BIOLOGICAL: Mycobacterium w|BIOLOGICAL: BCG (Bacillus Calmette-Guerin)
Recording of any clinical adverse reactions at anytime during the study for assessment of safety, 24 months|Recurrence Rate-Evaluated after 3 months by doing sonography, cystoscopy, and cytology, 24 months
Quality of Life- The measure of an individual's sense of well-being and ability to carry out various activities, 24 months|Time to Tumor progression -will be evaluated every 3 months for 15 months during the study period, 15
The purpose of this study is to determine and compare the effect of this treatment on recurrence rate and to assess the toxicity in both arms of patients with STCC. Other objectives include determining the effects of this treatment on quality of life, and comparing the effect of Mycobacterium w on time to tumor progression.